APLLTD

Alembic Pharmaceuticals Share PriceAlembic Pharmaceuticals

₹765.9
-7.7 (-1%)
As on 11 December, 2023 | 10:38 BSE: 533573 NSE: APLLTDISIN: INE901L01018

Alembic Pharmaceuticals Performance

Day Range

  • Low 763.45
  • High 777.75
₹ 765.9

52 Week Range

  • Low 462.30
  • High 839.00
₹ 765.9
  • Open Price775.00
  • Previous Close773.60
  • Volume28997

Start SIP in Alembic Pharmaceuticals

Start SIP

Alembic Pharmaceuticals Share Price

  • Over 1 Month 4.52%
  • Over 3 Month 0.19%
  • Over 6 Month 29.6%
  • Over 1 Year 27.7%

Alembic Pharmaceuticals Key Statistics

P/E Ratio 28.3
PEG Ratio 0.3
Market Cap Cr 15,055
Price to Book Ratio 3.4
EPS 17.6
Dividend 1
Relative Strength Index 62.56
Money Flow Index 87.81
MACD Signal -1.53
Average True Range 25.59

Alembic Pharmaceuticals Investment Rating

  • Master Rating:
  • Alembic Pharmaceuticals has an operating revenue of Rs. 5,996.55 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 7% is okay, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Alembic Pharmaceuticals Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1,4791,3321,3071,3101,3541,1601,304
Operating Expenses Qtr Cr 1,2711,1671,1381,0861,1091,0341,013
Operating Profit Qtr Cr 207166169224245127291
Depreciation Qtr Cr 67667466674646
Interest Qtr Cr 151414151296
Tax Qtr Cr 00-47252100
Net Profit Qtr Cr 1349813111914672251
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 5,1535,087
Operating Expenses Annual Cr 4,4854,127
Operating Profit Annual in Cr 664909
Depreciation Cr 273285
Interest Annual Cr 4917
Tax Annual Cr -1114
Net Profit Annual Cr 347544
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 730545
Cash from Investing Activity Annual Cr -461-369
Cash from Financing Annual Activity Cr -261-217
Net Cash Flow Annual Cr 8-40
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 4,4145,290
Fixed Assets Annual Cr 2,9794,075
Total Non Current Assets Annual Cr 3,3504,330
Total Current Assets Annual Cr 2,7802,744
Total Assets Annual Cr 6,1307,074
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 225269
ROE Annual % 810
ROCE Annual % 912
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1319
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1,5951,4861,4061,5091,4751,2621,416
Operating Expenses Qtr Cr 1,3871,2871,1941,2601,2421,2471,256
Operating Profit Qtr Cr 20819921224923315160
Depreciation Qtr Cr 686674676867123
Interest Qtr Cr 161414151297
Tax Qtr Cr -29-363318-2-2
Net Profit Qtr Cr 137121153122133-6635
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 5,6555,356
Operating Expenses Annual Cr 4,9444,432
Operating Profit Annual in Cr 708874
Depreciation Cr 275287
Interest Annual Cr 5018
Tax Annual Cr 13104
Net Profit Annual Cr 342521
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 724552
Cash from Investing Activity Annual Cr -448-372
Cash from Financing Annual Activity Cr -262-217
Net Cash Flow Annual Cr 14-37
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 4,3705,238
Fixed Assets Annual Cr 3,0004,102
Total Non Current Assets Annual Cr 3,2734,261
Total Current Assets Annual Cr 2,9102,861
Total Assets Annual Cr 6,1837,122
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 222266
ROE Annual % 810
ROCE Annual % 1012
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1317

Alembic Pharmaceuticals Technicals

EMA & SMA

Current Price
₹765.9
-7.7 (-1%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹748.93
  • 50 Day
  • ₹748.94
  • 100 Day
  • ₹731.49
  • 200 Day
  • ₹695.23
  • 20 Day
  • ₹743.20
  • 50 Day
  • ₹756.31
  • 100 Day
  • ₹756.88
  • 200 Day
  • ₹655.17

Alembic Pharmaceuticals Resistance and Support

PIVOT
₹778.2
Resistance
First Resistance 791.35
Second Resistance 809.10
Third Resistance 822.25
RSI 62.56
MFI 87.81
MACD Single Line -1.53
MACD 4.15
Support
First Resistance 760.45
Second Resistance 747.30
Third Resistance 729.55

Alembic Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 193,291 5,686,621 29.42
Week 169,120 6,829,066 40.38
1 Month 367,552 7,509,091 20.43
6 Month 275,607 9,916,338 35.98

Alembic Pharmaceuticals Result Highlights

Alembic Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Alembic Pharmaceutic is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5149.00 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2023. Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123.
Market Cap 15,058
Sales 5,428
Shares in Float 5.90
No of funds 176
Yield 1.03
Book Value 3.44
U/D Vol ratio 2.1
LTDebt / Equity
Alpha 0.06
Beta 0.82

Alembic Pharmaceuticals

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 69.61%69.61%69.61%69.61%
Mutual Funds 7.33%6.64%6.47%5.87%
Insurance Companies 6.57%6.74%6.55%6.6%
Foreign Portfolio Investors 4.51%4.34%4.55%4.99%
Financial Institutions/ Banks 0.03%0.03%0.04%0.04%
Individual Investors 8.24%8.98%9.08%9.21%
Others 3.71%3.66%3.7%3.68%

Alembic Pharmaceuticals Management

Name Designation
Mr. Chirayu Amin Chairman & CEO
Mr. Pranav Amin Managing Director
Mr. Shaunak Amin Managing Director
Mr. R K Baheti Director - Finance & CFO
Mr. K G Ramanathan Independent Director
Mr. Pranav Parikh Independent Director
Mr. Paresh Saraiya Independent Director
Dr. Archana Hingorani Independent Director
Mr. Ashok Barat Independent Director
Mr. Jai Diwanji Independent Director

Alembic Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Alembic Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-07 Quarterly Results
2023-08-04 Quarterly Results
2023-05-05 Audited Results & Final Dividend
2023-02-01 Quarterly Results
2022-11-11 Quarterly Results
Date Purpose Remarks
2023-07-28 FINAL Rs.8.00 per share(400%)Final Dividend
2022-08-18 INTERIM Rs.10.00 per share(500%)Dividend (Changed Final Dividend as Interim Divided)

Alembic Pharmaceuticals MF Shareholding

Name Amount(cr)
Axis Small Cap Fund Regular Growth 16,369
DSP Midcap Fund Growth 14,464
Kotak Small Cap Growth 12,163
DSP Small Cap Fund Regular Plan Growth 11,837
DSP ELSS Tax Saver Fund Regular Plan Growth 11,693

Alembic Pharmaceuticals FAQs

What is Share Price of Alembic Pharmaceuticals ?

Alembic Pharmaceuticals share price is ₹765 As on 11 December, 2023 | 10:24

What is the Market Cap of Alembic Pharmaceuticals ?

The Market Cap of Alembic Pharmaceuticals is ₹15054.8 Cr As on 11 December, 2023 | 10:24

What is the P/E ratio of Alembic Pharmaceuticals ?

The P/E ratio of Alembic Pharmaceuticals is 28.3 As on 11 December, 2023 | 10:24

What is the PB ratio of Alembic Pharmaceuticals ?

The PB ratio of Alembic Pharmaceuticals is 3.4 As on 11 December, 2023 | 10:24

Q2FY23